BIOTECH
David Elsley
President and CEO,
Cardiol Therapeutics
- President and CEO of Cardiol Therapeutics
Follow
About David
David Elsley, president and CEO of Cardiol Therapeutics, has more than 25 years of experience developing, financing, and managing all aspects of corporate development of biotechnology and high-growth organizations. He is also the founder and former president and CEO of Vasogen, Inc.